Talk to Sam
+1 718 473 0872
Search inside this page
Free Market Research Guides to Download
» View Public Reports5 reports
... Increasing uptake of benlysta, uloric, krystexxa, and the launch of oral tofacitinib to spur growth. The report provides insights into the rheumatology therapeutics market forecasts until 2018 and examines ...
... Adult source of cell to be used clinically has a generally weak therapeutic signal in many of the reported studies and trials. As the field matures, companies, researches, regulators, and clinicians ...
» Purchase Premium Reports (From $ 300 - $ 3 500)About 300 reports
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading ...
Reportlinker.com © Copyright 2014. All rights reserved.